Literature DB >> 10849014

The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia.

T J Smilde1, F W van den Berkmortel, H Wollersheim, H van Langen, J J Kastelein, A F Stalenhoef.   

Abstract

BACKGROUND: Early in the process of atherosclerosis, changes in vessel wall stiffness and thickness may occur. The present study evaluates the effect of cholesterol reduction on artery wall stiffness and intima media thickness in patients with familial hypercholesterolaemia (FH).
MATERIALS AND METHODS: Forty-five patients with familial hypercholesterolaemia (mean age 46+/-10 years) with untreated LDL cholesterol concentration > 9 mmol L(-1), were studied before and after one year of cholesterol lowering therapy with statins (simvastatin, atorvastatin 40-80 mg day(-1). The distensibility (DC in 10-3 kPa(-1) and compliance (CC in mm2. kPa(-1) of the common carotid artery (CCA) (right and left side) and common femoral artery (CFA) (right side) were determined by a wall track system (Pie Medical). The intima media thickness (IMT) (both right and left) of the CCA, bulb (BUL), internal carotid artery (ICA) and CFA were measured in mm by high-resolution ultrasound (Biosound).
RESULTS: The mean concentration of total cholesterol (TC), LDL-cholesterol (LDL-C) and triglycerides (TG) were reduced significantly by 43%, 51% and 25%, respectively, whereas HDL-cholesterol (HDL-C) increased by 13% (P<0.001). In the CFA, the DC and CC increased significantly (DC from 7.9+/-3.0 to 9.1+/-3.7 in 10(-3) kPa(-1); CC 0.5+/-0.2-0.6+/-0.3 in mm2. kPa(-1), whereas the DC and CC did not change in the CCA. In contrast, the IMT of the CCA decreased significantly in both men and women whereas an IMT decrease was also seen in the BUL and ICA in premenopausal women. A LDL-cholesterol reduction of 44.8% and 45.4% was necessary to induce significant decreases in IMT and increases in DC and CC.
CONCLUSIONS: One year of cholesterol lowering therapy in FH decreases the wall stiffness in the CFA and the arterial wall thickness in the CCA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849014     DOI: 10.1046/j.1365-2362.2000.00654.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

Review 1.  Comparing HMG-CoA reductase inhibitors.

Authors:  Peter H Jones
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 2.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk.

Authors:  Todd J Anderson
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

4.  LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.

Authors:  James McKenney; Christie M Ballantyne; Theodore A Feldman; William E Brady; Arvind Shah; Michael J Davies; Joanne Palmisano; Yale B Mitchel
Journal:  MedGenMed       Date:  2005-07-14

5.  Arterial Stiffness and Hypertension - Which Comes First?

Authors:  Monica Ecobici; Claudiu Stoicescu
Journal:  Maedica (Bucur)       Date:  2017-09

6.  Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.

Authors:  Adam G Goodwill; Stephanie J Frisbee; Phoebe A Stapleton; Milinda E James; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

7.  In vivo comparison of atherosclerotic plaque progression with vessel wall strain and blood flow velocity in apoE(-/-) mice with MR microscopy at 17.6 T.

Authors:  Volker Herold; Jeremy Wellen; Christian H Ziener; Thomas Weber; Karl-Heinz Hiller; Peter Nordbeck; Eberhard Rommel; Axel Haase; Wolfgang R Bauer; Peter M Jakob; Susanta K Sarkar
Journal:  MAGMA       Date:  2009-01-20       Impact factor: 2.310

Review 8.  Benefits and risks of simvastatin in patients with familial hypercholesterolaemia.

Authors:  Pedro Mata; Rodrigo Alonso; Juan Badimón
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Different effects of atherogenic lipoproteins and blood pressure on arterial structure and function: the Bogalusa Heart Study.

Authors:  Wei Chen; Sathanur R Srinivasan; Shengxu Li; Gerald S Berenson
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

10.  Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.

Authors:  Ioannis Protopsaltis; Stefanos Foussas; Angeliki Angelidi; Angelos Gritzapis; Theodoros Ν Sergentanis; Spyros Matsagos; Konstantinos Tzirogiannis; Georgios I Panoutsopoulos; Georgios Dimitriadis; Sotirios Raptis; Andreas Melidonis
Journal:  Cardiovasc Diabetol       Date:  2012-11-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.